Who We Are
Asia’s preferred healthcare market access partner.
Everlife is Asia’s leading market access and distribution partner for clinical diagnostics and laboratory sciences. By fusing technology with strong local knowledge, networks and infrastructure, we provide a unique value proposition to customers and business partners in a diverse region full of opportunity.
As experts in healthcare and Asia, we combine our commitment to high ethical standards with a passionate and driven approach to enable better outcomes not just for our customers and business partners, but for the region as a whole.
Principal Highlights
We don’t just build business, we build trust.
Our goal is to be Asia’s partner of choice for clinical diagnostics and laboratory sciences. We are bringing this vision to life by partnering with the world’s most trusted brands and bringing them to Asia. Our partners trust us because we invest in long-term win-win relationships that can improve outcomes for all our stakeholders.
- Dr. Naveen Agnihotri joins Everlife Asia as Senior Advisor of Digital and Technology
[Singapore, August 19, 2021]: Everlife Holdings Pte. Ltd. (“Everlife”) has welcomed Dr. Naveen Agnihotri to the company as Senior Advisor […]
- Ramesh Subrahmanian joins Everlife Board
[Singapore, July 2, 2021]: Everlife Holdings Pte. Ltd. (“Everlife”), a leading manufacturer and distributor of medical devices and laboratory equipment and consumables in Asia, has appointed […]
- Dr. Pramod Kabra appointed as Chief Executive Officer of CPC Diagnostics, a subsidiary of Everlife Asia
[Chennai, May 10, 2021]: CPC Diagnostics Pvt. Ltd. (“CPC”), a leading provider of In-Vitro Diagnostics (IVD) products and services in […]
- Chemopharm Launches E-Commerce Store in Malaysia
Kuala Lumpur, May 2021 – Chemopharm Sdn Bhd, Everlife’s subsidiary in Malaysia, has launched its new E-Commerce Store (“eStore”) in […]
Contact Us
